Semi-Annual Consolidated Balance Sheet

Delta-Fly Pharma, Inc. - Filing #7717381

Concept As at
2018-09-30
As at
2018-03-31
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
528,414,000 JPY
781,250,000 JPY
Other
28,177,000 JPY
50,457,000 JPY
Current assets
556,591,000 JPY
831,708,000 JPY
Non-current assets
Property, plant and equipment
30,441,000 JPY
30,898,000 JPY
Property, plant and equipment
Intangible assets
Intangible assets
102,000 JPY
120,000 JPY
Investments and other assets
1,419,000 JPY
1,418,000 JPY
Investments and other assets
Non-current assets
31,963,000 JPY
32,436,000 JPY
Assets
588,554,000 JPY
864,145,000 JPY
Liabilities
Current liabilities
Income taxes payable
5,870,000 JPY
2,224,000 JPY
Other
2,302,000 JPY
1,376,000 JPY
Current liabilities
35,017,000 JPY
28,593,000 JPY
Non-current liabilities
Long-term borrowings
9,662,000 JPY
13,058,000 JPY
Non-current liabilities
9,662,000 JPY
13,058,000 JPY
Liabilities
44,679,000 JPY
41,651,000 JPY
Net assets
Shareholders' equity
Share capital
1,117,500,000 JPY
1,117,500,000 JPY
Capital surplus
1,097,500,000 JPY
1,097,500,000 JPY
Retained earnings
-1,671,125,000 JPY
-1,392,506,000 JPY
Shareholders' equity
543,874,000 JPY
822,493,000 JPY
Net assets
543,874,000 JPY
822,493,000 JPY
Liabilities and net assets
588,554,000 JPY
864,145,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.